Luthra, N., Brown, E., Goldman, S., Zuzuarregui, R., Hue, T., Schambach, C., … Tanner, C. (2022). Enhancing Pandemic-Sensitive Recruitment Strategies for a Remote, Randomized Placebo-Controlled Trial for Fracture Prevention in Patients with Neurodegenerative Parkinsonisms (P1-1.Virtual). In NEUROLOGY (Vol. 98).

Luthra, Nijee, Ethan Brown, Samuel Goldman, Rafael Zuzuarregui, Trisha Hue, Christopher Schambach, Ian Bledsoe, et al. “Enhancing Pandemic-Sensitive Recruitment Strategies for a Remote, Randomized Placebo-Controlled Trial for Fracture Prevention in Patients with Neurodegenerative Parkinsonisms (P1-1.Virtual).” In NEUROLOGY, Vol. 98, 2022.

Luthra N, Brown E, Goldman S, Zuzuarregui R, Hue T, Schambach C, et al. Enhancing Pandemic-Sensitive Recruitment Strategies for a Remote, Randomized Placebo-Controlled Trial for Fracture Prevention in Patients with Neurodegenerative Parkinsonisms (P1-1.Virtual). In: NEUROLOGY. 2022.

Luthra, Nijee, et al. “Enhancing Pandemic-Sensitive Recruitment Strategies for a Remote, Randomized Placebo-Controlled Trial for Fracture Prevention in Patients with Neurodegenerative Parkinsonisms (P1-1.Virtual).” NEUROLOGY, vol. 98, no. 18, 2022.

Luthra N, Brown E, Goldman S, Zuzuarregui R, Hue T, Schambach C, Bledsoe I, Schwarzschild M, Dorsey ER, Espay A, Litvan I, McFarland N, Mitchell K, Standaert D, Beck J, Rowbotham H, Meng C, Perkins J, Ranola P, Picos R, Kriesel D, Lyles K, Cummings S, Tanner C. Enhancing Pandemic-Sensitive Recruitment Strategies for a Remote, Randomized Placebo-Controlled Trial for Fracture Prevention in Patients with Neurodegenerative Parkinsonisms (P1-1.Virtual). NEUROLOGY. 2022.